These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36812883)

  • 41. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
    Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
    Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?
    Haglund NA; Cox ZL; Lee JT; Song Y; Keebler ME; DiSalvo TG; Maltais S; Lenihan DJ; Wigger MA
    J Card Fail; 2014 Sep; 20(9):630-7. PubMed ID: 24954426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
    Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ
    Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation of standard heart failure assessment and palliative care questionnaires in a multidisciplinary heart failure clinic.
    Ezekowitz JA; Thai V; Hodnefield TS; Sanderson L; Cujec B
    J Pain Symptom Manage; 2011 Sep; 42(3):379-87. PubMed ID: 21444186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).
    Aljundi AHS; Mohammed SFK; Patel A; Singh R; Arabi A; AlBinali HA; Al Suwaidi J
    BMC Cardiovasc Disord; 2016 Feb; 16():47. PubMed ID: 26892533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Palliative Care Consultation Reduces Heart Failure Transitions: A Matched Analysis.
    Diop MS; Bowen GS; Jiang L; Wu WC; Cornell PY; Gozalo P; Rudolph JL
    J Am Heart Assoc; 2020 Jun; 9(11):e013989. PubMed ID: 32456514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series.
    Konstantino Y; Iakobishvili Z; Arad O; Ben-Gal T; Kusniec J; Mazur A; Porter A; Strasberg B; Battler A; Hasdai D
    Cardiology; 2006; 106(1):59-62. PubMed ID: 16612071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the ICD-9 Diagnostic Code for Palliative Care in Patients Hospitalized With Heart Failure Within the Veterans Health Administration.
    Feder SL; Redeker NS; Jeon S; Schulman-Green D; Womack JA; Tate JP; Bedimo RJ; Budoff MJ; Butt AA; Crothers K; Akgün KM
    Am J Hosp Palliat Care; 2018 Jul; 35(7):959-965. PubMed ID: 29254358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
    Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
    Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial.
    O'Donnell AE; Schaefer KG; Stevenson LW; DeVoe K; Walsh K; Mehra MR; Desai AS
    JAMA Cardiol; 2018 Jun; 3(6):516-519. PubMed ID: 29641819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis.
    Hernandez GA; Blumer V; Arcay L; Monge J; Viles-Gonzalez JF; Lindenfeld J; Goldberger JJ; Chaparro S
    JACC Heart Fail; 2018 Sep; 6(9):734-742. PubMed ID: 30098968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases.
    James KB; Militello M; Barbara G; Wilkoff BL
    Tex Heart Inst J; 2006; 33(1):19-22. PubMed ID: 16572863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
    Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
    Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation.
    Brekke PH; Omland T; Smith P; Søyseth V
    Respir Med; 2008 Sep; 102(9):1243-7. PubMed ID: 18595681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use and Discontinuation of Milrinone for Advanced Heart Failure in an Academic Palliative Care Unit: A Case Report and Discussion of Recommendations.
    Wolfe A; Watt CL; Downar J; Bush SH
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):24-33. PubMed ID: 35234559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.